Joseph P Lyssikatos - Net Worth and Insider Trading
Joseph P Lyssikatos Net Worth
The estimated net worth of Joseph P Lyssikatos is at least $25 Million dollars as of 2024-05-04. Joseph P Lyssikatos is the CHIEF SCIENTIFIC OFFICER of Enliven Therapeutics Inc and owns about 1,117,035 shares of Enliven Therapeutics Inc (ELVN) stock worth over $25 Million. Details can be seen in Joseph P Lyssikatos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph P Lyssikatos has not made any transactions after 2024-04-29 and currently still holds the listed stock(s).
Transaction Summary of Joseph P Lyssikatos
Joseph P Lyssikatos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph P Lyssikatos owns 1 companies in total, including Enliven Therapeutics Inc (ELVN) .
Click here to see the complete history of Joseph P Lyssikatos’s form 4 insider trades.
Insider Ownership Summary of Joseph P Lyssikatos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-04-29 | director & Chief Scientific Officer |
Joseph P Lyssikatos Latest Holdings Summary
Joseph P Lyssikatos currently owns a total of 1 stock. Joseph P Lyssikatos owns 1,117,035 shares of Enliven Therapeutics Inc (ELVN) as of April 29, 2024, with a value of $25 Million.
Latest Holdings of Joseph P Lyssikatos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-04-29 | 1,117,035 | 22.65 | 25,300,843 |
Holding Weightings of Joseph P Lyssikatos
Joseph P Lyssikatos Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph P Lyssikatos has made a total of 10 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 12,000 shares on April 29, 2024, which brought Joseph P Lyssikatos around $215,040.
Insider Trading History of Joseph P Lyssikatos
- 1
Joseph P Lyssikatos Trading Performance
Joseph P Lyssikatos Ownership Network
Joseph P Lyssikatos Owned Company Details
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Joseph P Lyssikatos is the director & Chief Scientific Officer of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Financial Officer Benjamin Hohl , director & President and CEO Samuel Kintz , and Chief Operating Officer Anish Patel .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Joseph P Lyssikatos made 10 insider transaction in Enliven Therapeutics Inc (ELVN) with a net sale of 126,000. Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 143,709 shares made by Samuel Kintz , a net sale of 51,625 shares made by Anish Patel , and a net sale of 40,000 shares made by Benjamin Hohl .
In summary, during the past 3 months, insiders sold 1,147,088 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,147,088 shares. During the past 18 months, 2,446,104 shares of Enliven Therapeutics Inc (ELVN) were sold and 622 shares were bought by its insiders, resulting in a net sale of 2,445,482 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
Joseph P Lyssikatos Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph P Lyssikatos. You might contact Joseph P Lyssikatos via mailing address: 6200 Lookout Road, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
